Submitted by Anonymous (not verified) on 30 September 2026 - 9:56
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 5, Status: Authorised